摘要
生物医药产业是全球各国竞相发展的战略新兴产业之一。本文通过对全球和我国生物医药领域专利公开情况进行检索和分析,分析生物医药领域研发热点和趋势;通过对全球生物医药专利公开量和拥有优先权申请的专利量的对比分析,总结我国与美国在生物医药市场吸引力及创新能力的差距和不足;同时对我国生物医药领域专利布局和发展提出了建议,为促进生物医药产业发展提供参考意见。研究发现,近5年全球生物医药领域专利公开增长迅速,其中我国生物医药领域专利公开量全球排名第2,复合年增长率为23.87%,远高于全球平均水平(4.09%),说明我国在本领域市场吸引力及创新能力不断提高;但同时也存在专利优先权数据上与美国有数量级的差距、发明专利相对比重小、企业申请人相对比重小等问题,说明我国在创新质量和创新主体上还有很大提升空间。建议在创新投入、院所评价、国际竞争和公共平台等方面引导和加大支持力度。
Healthcare industry is one of the emerging industries of strategic importance all around the world. By searching domestic and overseas information of patent publication,we analyzed hot research topics and trend of healthcare industry. By analyzing patent publication volume of global healthcare industry and the patent volume of application priority,we found some differences and deficiencies in innovation attractiveness and capacity between China and America. In the meanwhile,we proposed suggestions for healthcare patent portfolio and development so as to provide references for the development of healthcare industry. The study showed an upward trend of the healthcare publication volume in the last five years. China ranked second in the global healthcare publication volume with a compound annual growth rate of 23. 87%,which was much higher than the global average level（ 4. 09%）,demonstrating the increasing innovation attractiveness and capacity of China in this field. However,our patent volume of priority,innovation patent volume and numbers of enterprise applicants were much lower than that of America,indicating that there is still plenty to be promoted in innovation quality and subject. Thus,it is proposed to intensify guidance and support in innovation investment,evaluation of institutes,international competition and public platform.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2015年第15期1686-1693,共8页
Chinese Journal of New Drugs
基金
北京市科技专项(Z141110003214019)
关键词
生物医药
专利
创新能力
healthcare
patents
innovation ability
